With a sincere heart for life and a shared journey toward health, we will build a happier tomorrow.

Hello, and welcome. We sincerely thank our customers and shareholders for your continued support and trust.

In 1959, Kukje Pharma took its first steps carrying the noble mission of "Respect for Life" and "Public Health."

At a time when antibiotics were desperately needed, we devoted ourselves to protecting people from disease. That founding spirit has remained our greatest driving force for over 60 years. Keeping pace with the evolving needs of our time, we grew from an antibiotics specialist into a leader in ophthalmology from the mid-2000s onward, establishing ourselves as a key pillar of Korea's pharmaceutical industry.

Our growth is rooted not only in technological progress but also in our deep care for people.

We have introduced our incrementally modified drug (IMD), "Rebaeye Eye Drops," along with treatments for ophthalmic diseases and other therapeutic areas—made possible by our unwavering spirit of challenge, grounded in empathy for patients and a commitment to addressing unmet needs. Today, we remain dedicated to developing innovative therapeutics that improve quality of life, in close collaboration with leading research institutions in Korea and abroad.

We will fulfill our social responsibilities through transparent management and a culture of sharing.

Through state-of-the-art GMP facilities, we strive to supply medicines of the highest quality while contributing to society through responsible reinvestment and giving. Our customer-first principle is more than a slogan; it is a daily commitment.

With a history of trust built over more than 60 years, we now move forward toward our next century.

Going forward, we will continue to be a trusted partner in safeguarding lives and helping people regain healthy smiles. We will listen with humility and continue to earn trust through innovation.
We sincerely wish you continued health and happiness.
Thank you.

Nam Tae-hoon, Vice Chairman & CEO, Kukje Pharma